N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide

C118H101F6N19O9S2 — CID 161466847

IUPACN-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide
SMILESCc1cc(NC(=O)C2CCCO2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)C2CCOC2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)Cc2cccs2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)Cc2ccsc2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)[C@@H]2CCC(=O)N2)cc2c(-c3cccc(F)c3)[nH]nc12.O=C(Nc1cc2c(-c3ccc4ccccc4c3)n[nH]c2cc1F)C1CC1
InChIInChI=1S/C21H16FN3O.2C20H16FN3OS.C19H17FN4O2.2C19H18FN3O2/c22-17-11-18-16(10-19(17)23-21(26)13-6-7-13)20(25-24-18)15-8-5-12-3-1-2-4-14(12)9-15;1-12-8-15(22-18(25)11-16-6-3-7-26-16)10-17-19(12)23-24-20(17)13-4-2-5-14(21)9-13;1-12-7-16(22-18(25)8-13-5-6-26-11-13)10-17-19(12)23-24-20(17)14-3-2-4-15(21)9-14;1-10-7-13(21-19(26)15-5-6-16(25)22-15)9-14-17(10)23-24-18(14)11-3-2-4-12(20)8-11;1-11-8-14(21-19(24)16-6-3-7-25-16)10-15-17(11)22-23-18(15)12-4-2-5-13(20)9-12;1-11-7-15(21-19(24)13-5-6-25-10-13)9-16-17(11)22-23-18(16)12-3-2-4-14(20)8-12/h1-5,8-11,13H,6-7H2,(H,23,26)(H,24,25);2-10H,11H2,1H3,(H,22,25)(H,23,24);2-7,9-11H,8H2,1H3,(H,22,25)(H,23,24);2-4,7-9,15H,5-6H2,1H3,(H,21,26)(H,22,25)(H,23,24);2,4-5,8-10,16H,3,6-7H2,1H3,(H,21,24)(H,22,23);2-4,7-9,13H,5-6,10H2,1H3,(H,21,24)(H,22,23)/t;;;15-;;/m...0../s1
InChIKeyWCNWQKRNAAWQNT-VPPBVXFWSA-N
MW2107.35 g/mol
LogP25.05
Rot. Bonds20

About N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide

N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide (PubChem CID 161466847) has the molecular formula C118H101F6N19O9S2 and a molecular weight of 2107.35 g/mol. Its IUPAC name is N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide.

Molecular Properties

Compound NameN-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide
PubChem CID161466847
Molecular FormulaC118H101F6N19O9S2
Molecular Weight2107.35 g/mol
Exact Mass2105.74
IUPAC NameN-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide
SMILESCc1cc(NC(=O)C2CCCO2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)C2CCOC2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)Cc2cccs2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)Cc2ccsc2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)[C@@H]2CCC(=O)N2)cc2c(-c3cccc(F)c3)[nH]nc12.O=C(Nc1cc2c(-c3ccc4ccccc4c3)n[nH]c2cc1F)C1CC1
InChIInChI=1S/C21H16FN3O.2C20H16FN3OS.C19H17FN4O2.2C19H18FN3O2/c22-17-11-18-16(10-19(17)23-21(26)13-6-7-13)20(25-24-18)15-8-5-12-3-1-2-4-14(12)9-15;1-12-8-15(22-18(25)11-16-6-3-7-26-16)10-17-19(12)23-24-20(17)13-4-2-5-14(21)9-13;1-12-7-16(22-18(25)8-13-5-6-26-11-13)10-17-19(12)23-24-20(17)14-3-2-4-15(21)9-14;1-10-7-13(21-19(26)15-5-6-16(25)22-15)9-14-17(10)23-24-18(14)11-3-2-4-12(20)8-11;1-11-8-14(21-19(24)16-6-3-7-25-16)10-15-17(11)22-23-18(15)12-4-2-5-13(20)9-12;1-11-7-15(21-19(24)13-5-6-25-10-13)9-16-17(11)22-23-18(16)12-3-2-4-14(20)8-12/h1-5,8-11,13H,6-7H2,(H,23,26)(H,24,25);2-10H,11H2,1H3,(H,22,25)(H,23,24);2-7,9-11H,8H2,1H3,(H,22,25)(H,23,24);2-4,7-9,15H,5-6H2,1H3,(H,21,26)(H,22,25)(H,23,24);2,4-5,8-10,16H,3,6-7H2,1H3,(H,21,24)(H,22,23);2-4,7-9,13H,5-6,10H2,1H3,(H,21,24)(H,22,23)/t;;;15-;;/m...0../s1
InChIKeyWCNWQKRNAAWQNT-VPPBVXFWSA-N
XLogP25.05
TPSA394.24 Ų
H-Bond Donors13
H-Bond Acceptors17
Rotatable Bonds20
Heavy Atoms154
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002107.35
LogP ≤ 525.05
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1017

Analyze N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide?
The IUPAC name of N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide (CID 161466847) is N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide.
What is the SMILES notation for N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide?
The canonical SMILES for N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide is Cc1cc(NC(=O)C2CCCO2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)C2CCOC2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)Cc2cccs2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)Cc2ccsc2)cc2c(-c3cccc(F)c3)[nH]nc12.Cc1cc(NC(=O)[C@@H]2CCC(=O)N2)cc2c(-c3cccc(F)c3)[nH]nc12.O=C(Nc1cc2c(-c3ccc4ccccc4c3)n[nH]c2cc1F)C1CC1.
What is the InChIKey of N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide?
The InChIKey is WCNWQKRNAAWQNT-VPPBVXFWSA-N. The full InChI is InChI=1S/C21H16FN3O.2C20H16FN3OS.C19H17FN4O2.2C19H18FN3O2/c22-17-11-18-16(10-19(17)23-21(26)13-6-7-13)20(25-24-18)15-8-5-12-3-1-2-4-14(12)9-15;1-12-8-15(22-18(25)11-16-6-3-7-26-16)10-17-19(12)23-24-20(17)13-4-2-5-14(21)9-13;1-12-7-16(22-18(25)8-13-5-6-26-11-13)10-17-19(12)23-24-20(17)14-3-2-4-15(21)9-14;1-10-7-13(21-19(26)15-5-6-16(25)22-15)9-14-17(10)23-24-18(14)11-3-2-4-12(20)8-11;1-11-8-14(21-19(24)16-6-3-7-25-16)10-15-17(11)22-23-18(15)12-4-2-5-13(20)9-12;1-11-7-15(21-19(24)13-5-6-25-10-13)9-16-17(11)22-23-18(16)12-3-2-4-14(20)8-12/h1-5,8-11,13H,6-7H2,(H,23,26)(H,24,25);2-10H,11H2,1H3,(H,22,25)(H,23,24);2-7,9-11H,8H2,1H3,(H,22,25)(H,23,24);2-4,7-9,15H,5-6H2,1H3,(H,21,26)(H,22,25)(H,23,24);2,4-5,8-10,16H,3,6-7H2,1H3,(H,21,24)(H,22,23);2-4,7-9,13H,5-6,10H2,1H3,(H,21,24)(H,22,23)/t;;;15-;;/m...0../s1.
What are the key properties of N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide?
N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide has a molecular weight of 2107.35 g/mol, XLogP of 25.05, 20 rotatable bonds, 13 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-(6-fluoro-3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]oxolane-3-carboxamide;(2S)-N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-2-ylacetamide;N-[3-(3-fluorophenyl)-7-methyl-2H-indazol-5-yl]-2-thiophen-3-ylacetamide is sourced from PubChem (CID 161466847), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).